885326-88-5 Usage
General Description
2-Amino-4-bromo-6-carboxypyridine methyl ester is a chemical compound with the molecular formula C6H6BrN2O2. It is a derivative of pyridine and contains an amino group, a bromine atom, and a carboxyl group. 2-Amino-4-bromo-6-carboxypyridine methyl ester is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various biologically active molecules. It has potential applications in the development of new drugs and pharmaceuticals due to its structural features and reactivity. Additionally, it may also have applications in other fields such as materials science and agrochemicals. The compound's specific properties and reactivity make it a valuable intermediate in the production of a wide range of chemical and pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 885326-88-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,3,2 and 6 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 885326-88:
(8*8)+(7*8)+(6*5)+(5*3)+(4*2)+(3*6)+(2*8)+(1*8)=215
215 % 10 = 5
So 885326-88-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H7BrN2O2/c1-12-7(11)5-2-4(8)3-6(9)10-5/h2-3H,1H3,(H2,9,10)
885326-88-5Relevant articles and documents
POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1
-
Paragraph 0298; 0301, (2020/05/14)
Described are positive allosteric modulators of muscarinic acetylcholine receptor M1 (mAChR M1), pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating neurological disorders, psychiatric disorders, or a combination thereof.
IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS HISTONE DEMETHYLASE INHIBITORS
-
Paragraph 0133, (2018/01/15)
This disclosure relates, inter alia, to compounds that inhibit histone demethylase activity. In particular, the disclosure relates to compounds that inhibit histone lysine demethylase KDM5B, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions disclosed herein.
